CDKN1C antibody (pThr310)

Catalog No. ABIN7182289

The Rabbit Polyclonal anti-CDKN1C antibody (ABIN7182289) specifically detects CDKN1C in WB, IF, IHC and ELISA. The antibody is reactive with Human samples.

Quick Overview for CDKN1C antibody (pThr310) (ABIN7182289)

Target: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CDKN1C antibody is un-conjugated

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), ELISA

Product Details anti-CDKN1C Antibody

Binding Specificity: pThr310

Purpose: Phospho-CDKN1C (T310) Antibody

Cross-Reactivity: Mouse

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen: Synthesized peptide derived from Human p57 around the phosphorylation site of T310.

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for CDKN1C

Target: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Alternative Name: CDKN1C

Background: Beckwith Wiedemann syndrome antibody, BWCR antibody, BWS antibody, CDKI antibody, CDKN 1C antibody, CDKN1C antibody, CDN1C_HUMAN antibody, Cyclin dependent kinase inhibitor 1C antibody, Cyclin dependent kinase inhibitor p57 antibody, Cyclin-dependent kinase inhibitor 1C antibody, Cyclin-dependent kinase inhibitor p57 antibody, KIP 2 antibody, KIP2 antibody, p57 antibody, p57 Kip 2 antibody, p57KIP2 antibody, WBS antibody

UniProt: P49918

Pathways: Cell Division Cycle, Dopaminergic Neurogenesis